SCHEMBL31346012

SCHEMBL31346012

Fc1cc2c(cc1Cl)OC(c1cccc(-c3nnn[nH]3)c1)C2

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346000 0.96 FFAR1 (0.35) FFAR1
SCHEMBL31346062 0.91 FFAR1 (0.35) FFAR1
SCHEMBL31345964 0.91 FFAR1 (0.37) FFAR1
SCHEMBL31346050 0.88 FFAR1 (0.39) FFAR1
SCHEMBL31345975 0.85 FFAR1 (0.41) FFAR1
SCHEMBL31346009 0.79 FFAR1 (0.37) FFAR1
SCHEMBL31346111 0.79 FFAR1 (0.37) FFAR1
SCHEMBL31346007 0.79 HTR1A (0.34) FFAR1
SCHEMBL31345965 0.79 FFAR1 (0.37) FFAR1
SCHEMBL31346165 0.79 EZH2 (0.33) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed